RIPK4 Is an Immune Regulating-Associated Biomarker for Ovarian Cancer and Possesses Generalization Value in Pan-Cancer

Ovarian cancer (OC) is the most lethal gynecologic cancer. Many studies have reported that RIPK4 (receptor interacting serine/threonine kinase 4) displayed a dysregulated level in many types of tumors. However, its expressions and functions in OC were rarely reported. The levels of RIPK4 were detect...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Cui, Zhao, Yi-xia, Han, Wei-di, Lai, Nian-yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926548/
https://www.ncbi.nlm.nih.gov/pubmed/35310605
http://dx.doi.org/10.1155/2022/7599098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926548/
https://www.ncbi.nlm.nih.gov/pubmed/35310605
http://dx.doi.org/10.1155/2022/7599098

Ejemplares similares